Avandamet: Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes

C.J Bailey*, C. Day

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Avandamet: Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences